NCT02935075View on ClinicalTrials.gov

Optimization of Antiretroviral Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

June 5, 2019

Study Completion Date

August 31, 2019

Conditions
HIV Infections
Interventions
DRUG

Tenofovir disoproxil fumarate

Oral daily

DRUG

Lamivudine

Oral daily

DRUG

Efavirenz

Oral daily

Trial Locations (3)

201508

Shanghai Public Health Clinical Center, Shanghai

210003

The Second Hospital of Nanjing, Nanjing

650041

Yunnan AIDS care center, Kunming

All Listed Sponsors
collaborator

Yunnan Provincial Infectious Disease Hospital

OTHER

collaborator

The Second Hospital of Nanjing Medical University

OTHER

lead

Shanghai Public Health Clinical Center

OTHER_GOV

NCT02935075 - Optimization of Antiretroviral Therapy | Biotech Hunter | Biotech Hunter